Alzheimer’s expert speaks at Nov. 8 symposium

WARWICK – During November, Rhode Islanders recognize the impact of caregiving and honor the more than 15 million Americans caring for someone with Alzheimer’s Disease.

You can learn more about innovations in Alzheimer’s disease research with Dr. Richard Mohs by taking part in the Alzheimer’s Association, Rhode Island Chapter’s annual Brian R. Ott M.D. Research Symposium on Thursday Nov. 8, at the Radisson Hotel Providence Airport in Warwick. Reception and cash bar open at 5:30 p.m., with the presentation beginning at 6.

This year’s guest speaker, Richard Mohs, PhD, will focus on “Why it is so Hard to Find New Medicines for Alzheimer’s disease.” Richard C. Mohs, PhD is the Chief Scientific Officer for the Global Alzheimer’s Platform (GAP) Foundation.

In addition to his work for the GAP Foundation, Dr. Mohs serves as a consultant to Agenebio, a Baltimore-based company developing an SV2A antagonist for treatment of mild cognitive impairment. He also serves as a member of the Board of Governors for the Alzheimer’s Drug Discovery Foundation in New York, a member of the Board of Directors for Cog State Ltd, based in Melbourne, Australia, and as senior associate editor for Alzheimer’s and Dementia, the journal of the Alzheimer’s Association.

The Alzheimer’s Association reports that more than 5 million Americans are living with Alzheimer’s disease, including an estimated 200,000 under the age of 65. By 2050, that number is expected to triple, affecting 16 million Americans. Alzheimer’s disease is the only condition among the nation’s leading causes of death that cannot be fully prevented, slowed, or cured.

The symposium is free to attend and open to the public, but pre-registration is required. Contact the Alzheimer’s Association, Rhode Island Chapter’s office to pre-register at 1-800272-3900 or visit communityresourcefinder. org.